Tyra Biosciences Inc (TYRA)

Tyra Biosciences Inc (TYRA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.5B; returns 1 day -2.0%, 1 week +10.4%, 1 year +44.8%.

Tyra Biosciences Inc. is a clinical-stage biotechnology company focused on developing next-generation precision medicines by targeting Fibroblast Growth Factor Receptor (FGFR) biology, leveraging its proprietary SNÅP platform for rapid and precise drug design.

Groups TYRA belongs to

• Biotechnology
• Clinical Stage Biotech
• Precision Medicine
• Healthcare
• Clinical Stage
• Oncology
• Rare Diseases
• Life Sciences
• Biopharmaceutical
• Drug Discovery
• Pharmaceuticals
• R&D

TYRA financial model: income statement, cash flow and balance sheet